Albert Einstein College of Medicine

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Albert Einstein College of Medicine sits in the top decile of US sponsors by registered trial count (#169 of 15,742 sponsors by registered trial count).

175 total trials 20 currently recruiting 121 completed early-phase tilt top decile by trial count

Albert Einstein College of Medicine: 175 sponsored US clinical trials, 20 recruiting.

Albert Einstein College of Medicine sponsors 175 registered US clinical trials on ClinicalTrials.gov, 20 of them currently recruiting, and 121 completed. 17 of these trials are in Phase 3-4 (later-stage) and 49 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Pain, with 5 trials.

Top-decile sponsor footprint

Albert Einstein College of Medicine ranks in the top decile of sponsors by registered trial count (#169 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 44/100

121 of 148 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

175 total, page 2 of 4

COMPLETED NA

Movement Intervention for Memory Enhancement

NCT03475316

TERMINATED Phase 4

Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)

NCT03608163

COMPLETED Phase 3

IV Acetaminophen as Adjuvant Analgesic to Hydromorphone - Emergency Department Patients

NCT03553498

TERMINATED Phase 2

Low Dose Aprepitant for Patients Receiving Carboplatin

NCT03237611

COMPLETED Phase 4

A Trial of Directly Observed and Long-term Varenicline

NCT03365362

COMPLETED NA

Multicultural Healthy Diet to Reduce Cognitive Decline

NCT03240406

COMPLETED

MEMO-Medical Marijuana and Opioids Study

NCT03268551

COMPLETED NA

Comparison of Healthy Diets on Breast Cancer Markers

NCT02744079

COMPLETED NA

Sleep Health Literacy in Head Start

NCT03556462

COMPLETED

Medical Cannabis During Chemoradiation for Head and Neck Cancer

NCT03431363

TERMINATED

New Daily Persistent Headache Biomarkers Study

NCT04260087

TERMINATED NA

MRI Only Radiation Therapy With CPAP

NCT03397342

COMPLETED Early Phase 1

Studies of Sulfur Metabolism in Humans

NCT03383133

COMPLETED NA

Obesity and Caries in Young South Asian Children: A Common Risk Factor Approach

NCT03077425

COMPLETED Phase 2

Comparing Five Oral Analgesics for Treatment of Acute Pain in the Emergency Department (ED)

NCT03173456

COMPLETED NA

Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs

NCT03127358

COMPLETED NA

Motor Imagery Intervention for Improving Gait and Cognition in the Elderly

NCT02762604

COMPLETED NA

The Influence of Breakfast on Hormone Responses and Cognitive Performance

NCT03005951

COMPLETED Phase 2

Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer

NCT03481114

TERMINATED Phase 2

Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer

NCT03848182

TERMINATED Early Phase 1

Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes

NCT02774291

COMPLETED

Developmental Impact of NICU Exposures (DINE)

NCT03061890

COMPLETED Phase 1

Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery

NCT06867068

COMPLETED NA

Childhood Asthma Perception Study

NCT02702687

COMPLETED Phase 1

Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

NCT03403049

COMPLETED Phase 3

Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives

NCT02757872

COMPLETED NA

Cognitive Remediation to Improve Mobility in Sedentary Seniors

NCT02567227

COMPLETED NA

Sensory Integration Therapy in Autism: Mechanisms and Effectiveness

NCT02536365

COMPLETED NA

PowerUp for Health: A Diabetes Prevention Program for Men

NCT02555631

COMPLETED NA

Prevention of Severe Acute Respiratory Failure in Patients With PROOFCheck

NCT02488174

COMPLETED NA

Bronx MBCT-Migraine

NCT02443519

COMPLETED NA

Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery

NCT02527304

COMPLETED NA

Acupuncture Approaches for Chronic Pain

NCT02456727

COMPLETED NA

Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies

NCT02578888

COMPLETED

The Role of the Pregnane X Receptor (PXR) in Indole Signaling and Intestinal Permeability in Inflammatory Bowel Disease

NCT04089501

COMPLETED Phase 1

Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

NCT02009436

TERMINATED

Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease

NCT02445144

COMPLETED Phase 4

Metformin in Longevity Study (MILES).

NCT02432287

COMPLETED Phase 1

Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop

NCT02328040

COMPLETED NA

Group-based Chronic Kidney Disease Care

NCT02467894

COMPLETED NA

Translating Telephonic Diabetes Self-management Support to Primary Care Practice

NCT02137720

TERMINATED Phase 2

Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer

NCT02112552

COMPLETED NA

Comparison of High Versus Low Bicarbonate Hemodialysis

NCT02098356

COMPLETED Phase 1

Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects

NCT02053935

TERMINATED Phase 1

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant

NCT02038153

COMPLETED Phase 1

Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring

NCT02006264

TERMINATED Phase 2

Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer

NCT01857271

COMPLETED NA

Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors

NCT02575872

TERMINATED NA

Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery

NCT01958580

TERMINATED NA

Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant

NCT01899326

← Previous Page 2 of 4 Next →

Phase Distribution

PhaseTrial count
Phase 1 20
Phase 2 29
Phase 3 5
Phase 4 12

What is open in the Albert Einstein College of Medicine pipeline

20 recruiting of 175 indexed (11% open); 121 completed (69%).

Phase mix: 17 late (III/IV) vs 49 early (I/II) (early-phase heavy).

Top condition: Chronic Pain (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Albert Einstein College of Medicine: open-pipeline peers nationwide

Peers matched on 175 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

Albert Einstein College of Medicine sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 0%5%10%15%20% Total trials Recruiting share Albert Einstein College of MedicineBausch & Lomb IncorporatedUConn HealthBaylor Research InstituteAbbottUniversity of MemphisChildren's Mercy Hospital Kansas CityJanssen Research & DevelopmentBarbara Ann Karmanos Cancer Institute
Albert Einstein College of Medicine sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Albert Einstein College of Medicine sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 175 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

What to do with this Albert Einstein College of Medicine page

175 registered trials is a research-attention snapshot, not an endorsement of Albert Einstein College of Medicine or any single study.

  • 20 of Albert Einstein College of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Chronic Pain is the condition Albert Einstein College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Albert Einstein College of Medicine pipeline card: 175 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.